Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

159 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
No clear influence of treatment escalation on flare prevention in serologically active clinically quiescent patients with systemic lupus erythematosus: a retrospective cohort study.
Ayano M, Hirata A, Tokunaga S, Furuhashi H, Kimoto Y, Ono N, Arinobu Y, Nakashima N, Akashi K, Horiuchi T, Niiro H. Ayano M, et al. Among authors: niiro h. Rheumatol Int. 2024 Apr 26. doi: 10.1007/s00296-024-05593-6. Online ahead of print. Rheumatol Int. 2024. PMID: 38668884
Correction to: Effectiveness and safety of sarilumab in patients with rheumatoid arthritis: A multicenter, retrospective, inverse probability of treatment-weighted analysis based on the FRAB-registry.
Harada H, Kondo M, Maeyama A, Fukuda T, Ikemura S, Shono E, Tsuru T, Inoue Y, Yoshizawa S, Niiro H, Nakashima Y. Harada H, et al. Among authors: niiro h. Clin Rheumatol. 2024 May;43(5):1787-1791. doi: 10.1007/s10067-024-06907-6. Clin Rheumatol. 2024. PMID: 38489137 No abstract available.
GWAS for systemic sclerosis identifies six novel susceptibility loci including one in the Fcγ receptor region.
Ishikawa Y, Tanaka N, Asano Y, Kodera M, Shirai Y, Akahoshi M, Hasegawa M, Matsushita T, Saito K, Motegi SI, Yoshifuji H, Yoshizaki A, Kohmoto T, Takagi K, Oka A, Kanda M, Tanaka Y, Ito Y, Nakano K, Kasamatsu H, Utsunomiya A, Sekiguchi A, Niiro H, Jinnin M, Makino K, Makino T, Ihn H, Yamamoto M, Suzuki C, Takahashi H, Nishida E, Morita A, Yamamoto T, Fujimoto M, Kondo Y, Goto D, Sumida T, Ayuzawa N, Yanagida H, Horita T, Atsumi T, Endo H, Shima Y, Kumanogoh A, Hirata J, Otomo N, Suetsugu H, Koike Y, Tomizuka K, Yoshino S, Liu X, Ito S, Hikino K, Suzuki A, Momozawa Y, Ikegawa S, Tanaka Y, Ishikawa O, Takehara K, Torii T, Sato S, Okada Y, Mimori T, Matsuda F, Matsuda K, Amariuta T, Imoto I, Matsuo K, Kuwana M, Kawaguchi Y, Ohmura K, Terao C. Ishikawa Y, et al. Among authors: niiro h. Nat Commun. 2024 Jan 31;15(1):319. doi: 10.1038/s41467-023-44541-z. Nat Commun. 2024. PMID: 38296975 Free PMC article.
Streptococcal Toxic Shock Syndrome due to Streptococcus dysgalactiae subsp. equisimilis from Retroperitoneal Panniculitis during the treatment with anti-IL-6 receptor antibody: A Case Report.
Fujimoto S, Eriguchi Y, Nakamura R, Kamikawa S, Yonekawa A, Miyake N, Ono N, Niiro H. Fujimoto S, et al. Among authors: niiro h. Mod Rheumatol Case Rep. 2024 Jan 12:rxae001. doi: 10.1093/mrcr/rxae001. Online ahead of print. Mod Rheumatol Case Rep. 2024. PMID: 38217091
Effectiveness and safety of sarilumab in patients with rheumatoid arthritis: A multicenter, retrospective, inverse probability of treatment-weighted analysis based on the FRAB-registry.
Harada H, Kondo M, Maeyama A, Fukuda T, Ikemura S, Shono E, Tsuru T, Inoue Y, Yoshizawa S, Niiro H, Nakashima Y. Harada H, et al. Among authors: niiro h. Clin Rheumatol. 2024 May;43(5):1447-1459. doi: 10.1007/s10067-023-06862-8. Epub 2024 Jan 6. Clin Rheumatol. 2024. PMID: 38182801
Recent advances in the treatment strategy for AAV improved outcomes with intensive GC tapering.
Ono N, Kai T, Takeyama Y, Inoue Y, Ueda N, Nagano S, Ohta S, Inoue H, Sawabe T, Chifu Y, Yoshizawa S, Oryoji K, Kimoto Y, Miyake K, Ayano M, Mitoma H, Arinobu Y, Miyamura T, Horiuchi T, Akashi K, Tada Y, Niiro H. Ono N, et al. Among authors: niiro h. Int J Rheum Dis. 2024 Jan;27(1):e15009. doi: 10.1111/1756-185X.15009. Epub 2023 Dec 21. Int J Rheum Dis. 2024. PMID: 38129977
Granzyme K- and amphiregulin-expressing cytotoxic T cells and activated extrafollicular B cells are potential drivers of IgG4-related disease.
Koga R, Maehara T, Aoyagi R, Munemura R, Murakami Y, Doi A, Kono M, Yamamoto H, Niiro H, Kiyoshima T, Tanabe M, Nakano T, Matsukuma Y, Kawano M, Stone JH, Pillai S, Nakamura S, Kawano S. Koga R, et al. Among authors: niiro h. J Allergy Clin Immunol. 2024 Apr;153(4):1095-1112. doi: 10.1016/j.jaci.2023.11.916. Epub 2023 Dec 11. J Allergy Clin Immunol. 2024. PMID: 38092138
159 results